Health
J&J’s COVID-19 vaccine generates positive pre-clinical results – PMLiVE
Experimental vaccine begins first-in-human trial this month
An experimental vaccine candidate currently being developed by Johnson and Johnson has proved promising in early, pre-clinical studies.
The vaccine, Ad26.COV2.S, induced a robust immune response in monkeys, demonstrated by high levels of neutralising antibodies. According to J&J, this immune response successfully prevented subsequent infection and provided complete or near-complete protection from the SARS-CoV-2 virus, which causes COVID-19.
In the studies, J&J’s researchers initially…
-
Noosa News22 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News23 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
General20 hours agoDairy farmers devastated by floods across parts of New South Wales
-
General23 hours ago‘Aussie Cossack’ Simeon Boikov’s legal fees paid by fund linked to Russian intelligence